Sheldon Koenig

Director Ejecutivo en ESPERION THERAPEUTICS, INC. .

60 años

Health Technology

Consumer Services

Perfil

Sheldon L.
Koenig is the founder of Nuvig Therapeutics, Inc. Mr. Koenig is President & Chief Executive Officer at Esperion Therapeutics, Inc. since 2026.
Formerly, Mr. Koenig was Vice President at Merck & Co., Inc. from 2009 to 2015.
Mr. Koenig was Chief Commercial Officer & Executive VP at Portola Pharmaceuticals LLC from 2019 to 2020.
Mr. Koenig was Senior VP & Head-Cardiovascular Franchise at Sanofi Corp.
Education includes an undergraduate degree from Drexel University and an MBA from Monmouth University.

Cargos activos de Sheldon Koenig

Empresas	Cargo	Inicio
ESPERION THERAPEUTICS, INC.	Director Ejecutivo	18/05/2021

Todos los cargos activos de Sheldon Koenig

Antiguos cargos conocidos de Sheldon Koenig.

Empresas	Cargo	Fin
PORTOLA PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/08/2020
MERCK & CO., INC.	Corporate Officer/Principal	01/01/2015
Nuvig Therapeutics, Inc. Nuvig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops translating novel therapeutics medicine for autoimmune diseases	Fundador	-
Sanofi Corp. Sanofi Corp. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi Corp. is a biopharmaceutical company dedicated to improving health outcomes through innovative medicines, vaccines, and patient-centered care. The company is based in Bridgewater, NJ. The company offers a broad portfolio including prescription medicines across therapeutic areas such as immunology, neurology, oncology, rare diseases, cardiovascular disease, diabetes, and transplant, alongside an extensive range of vaccines protecting against infectious diseases like influenza, respiratory syncytial virus (RSV), dengue, and COVID-19. Sanofi emphasizes scientific innovation with a robust R&D pipeline comprising clinical-stage projects, including advanced therapies like bispecific antibodies, gene therapies, and mRNA vaccines. The company addresses complex conditions such as chronic graft-versus-host disease in transplant patients and rare blood disorders like immune thrombocytopenia purpura, having launched therapies in these areas. Sanofi collaborates with healthcare professionals, patient communities, advocacy groups, and governments to expand access, promote holistic care, and advance science. Social impact initiatives focus on health equity, inclusion, environmental factors affecting respiratory health, and responsible business practices. Sanofi provides resources for healthcare providers and patients, including prescribing information, patient support, and educational materials, and maintains transparent communication through media channels and regular updates on financial performance, regulatory approvals, and clinical trial progress.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Sheldon Koenig.

Formación de Sheldon Koenig.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Sheldon Koenig.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	7
Merck & Co., Inc. Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines	Health Technology
Esperion Therapeutics, Inc. Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products	Health Technology
Portola Pharmaceuticals LLC Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics	Health Technology
Drexel University Drexel University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Monmouth University Monmouth University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sanofi Corp. Sanofi Corp. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi Corp. is a biopharmaceutical company dedicated to improving health outcomes through innovative medicines, vaccines, and patient-centered care. The company is based in Bridgewater, NJ. The company offers a broad portfolio including prescription medicines across therapeutic areas such as immunology, neurology, oncology, rare diseases, cardiovascular disease, diabetes, and transplant, alongside an extensive range of vaccines protecting against infectious diseases like influenza, respiratory syncytial virus (RSV), dengue, and COVID-19. Sanofi emphasizes scientific innovation with a robust R&D pipeline comprising clinical-stage projects, including advanced therapies like bispecific antibodies, gene therapies, and mRNA vaccines. The company addresses complex conditions such as chronic graft-versus-host disease in transplant patients and rare blood disorders like immune thrombocytopenia purpura, having launched therapies in these areas. Sanofi collaborates with healthcare professionals, patient communities, advocacy groups, and governments to expand access, promote holistic care, and advance science. Social impact initiatives focus on health equity, inclusion, environmental factors affecting respiratory health, and responsible business practices. Sanofi provides resources for healthcare providers and patients, including prescribing information, patient support, and educational materials, and maintains transparent communication through media channels and regular updates on financial performance, regulatory approvals, and clinical trial progress.	Health Technology
Nuvig Therapeutics, Inc. Nuvig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops translating novel therapeutics medicine for autoimmune diseases	Health Technology